These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Stenotic esophagitis appearing during severe digestive episodes due to sulfamethoxypyridazine intolerance]. Voilque G JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1973 Dec; 22(10):923-5. PubMed ID: 4275545 [No Abstract] [Full Text] [Related]
6. Warning against prolonged-action sulfonamides. Med Lett Drugs Ther; 1966 Feb; 8(4):13-4. PubMed ID: 5907884 [No Abstract] [Full Text] [Related]
7. [Labile infiltrate induced by a long-acting sulfonamide]. Gascard E; Boutin C; Cargnino P; Girbal JP Mars Med; 1969; 106(11):891-3. PubMed ID: 5407167 [No Abstract] [Full Text] [Related]
8. [Prevention of infection in chronic bronchopulmonary disease. Experiences with the ultra-long acting sulfonamide, Kelfizin (Longum)]. Roggenbach HJ; Schmidt S Munch Med Wochenschr; 1970 Nov; 112(46):2094-7. PubMed ID: 4999303 [No Abstract] [Full Text] [Related]
9. The activity of thiacetazone, thiambutosine, thiocarlide and sulphamethoxypyridazine against Mycobacterium leprae in mice. Colston MJ; Hilson GR; Ellard GA; Gammon PT Lepr Rev; 1978 Jun; 49(2):101-13. PubMed ID: 78428 [No Abstract] [Full Text] [Related]
10. [Prospective comparison between nitrofurantoin and sulphamethoxydiazine in the long-term therapy of children suffering from severe chronic recurrent pyelonephritis]. Olbing H; Reischauer HC; Kovacs I Dtsch Med Wochenschr; 1970 Dec; 95(49):2469-73. PubMed ID: 4992056 [No Abstract] [Full Text] [Related]
14. New aspects in the therapeutic application of sulphamethoxypyridazine. KAROLYHAZY G; KOVACS E; KOVACS MB Ther Hung; 1962; 10():33-5. PubMed ID: 13962573 [No Abstract] [Full Text] [Related]
15. Pneumonia in childhood treated with a single dose of sulphamethoxypyridazine. LANGKILDE M Dan Med Bull; 1963 Apr; 10():39-41. PubMed ID: 13928655 [No Abstract] [Full Text] [Related]
16. [Fibrosing alveolitis--a contribution to the ultrastructure and pathogenesis of interstitial pulmonary diseases (author's transl)]. Gebbers JO; Seifert G; Riesner K Rontgenblatter; 1977 Nov; 30(11):539-50. PubMed ID: 73212 [TBL] [Abstract][Full Text] [Related]
17. Hypothesis: exposure to solvents may cause fibrosing alveolitis. Billings CG; Howard P Eur Respir J; 1994 Jun; 7(6):1172-6. PubMed ID: 7925888 [TBL] [Abstract][Full Text] [Related]
18. [Alveolitis and lung fibroses caused by drugs]. Liebetrau G; Pielesch W Z Gesamte Inn Med; 1987 Oct; 42(20):589-91. PubMed ID: 3433846 [TBL] [Abstract][Full Text] [Related]
19. TOXIC HEPATITIS DUE TO SULPHAMETHOXYPYRIDAZINE. JOHNSON PJ; EVANS DW Br J Clin Pract; 1964 Dec; 18():749. PubMed ID: 14239666 [No Abstract] [Full Text] [Related]
20. [Hemolytic anemia after treatment with sulfamethoxypyridazine in a child with temporary G-6-PD deficiency and grave hypothyroidism]. Chieffi A; Bartolozzi G; Benedetti P Riv Clin Pediatr; 1967; 80(4):61-2. PubMed ID: 5629125 [No Abstract] [Full Text] [Related] [Next] [New Search]